To test our hypothesis that antibodies from sustained responders are uniquely able to block IgE binding to Ara h 2, we used peanut-allergy plasma pooled from placebo-treated OIT patients (n = 6) in an indirect competitive ELISA. Here, IGHE is linked to allergic disease.